In the last trading session, 1.55 million shares of the Clover Health Investments Corp (NASDAQ:CLOV) were traded, and its beta was 2.02. Most recently the company’s share price was $3.57, and it changed around -$0.07 or -2.06% from the last close, which brings the market valuation of the company to $1.79B. CLOV currently trades at a discount to its 52-week high of $4.87, offering almost -36.41% off that amount. The share price’s 52-week low was $0.61, which indicates that the current value has risen by an impressive 82.91% since then.
Clover Health Investments Corp stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended CLOV as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Clover Health Investments Corp is expected to report earnings per share of -0.07 for the current quarter.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Instantly CLOV has showed a red trend with a performance of -2.06% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 4.52 on recent trading dayincreased the stock’s daily price by 21.02%. The company’s shares are currently up 13.17% year-to-date, but still down -17.67% over the last five days. On the other hand, Clover Health Investments Corp (NASDAQ:CLOV) is -18.79% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 40.5% from its current value. Analyst projections state that CLOV is forecast to be at a low of $6 and a high of $6.
Clover Health Investments Corp (CLOV) estimates and forecasts
The year-over-year growth rate is expected to be 36.00%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 466.93M in revenue for the current quarter. 4 analysts expect Clover Health Investments Corp to make 474.88M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 346.92M and 356.26M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 34.59%. Forecasts for the next quarter put sales growth at 33.30%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -237.67%. Clover Health Investments Corp earnings are expected to increase by -80.25% in 2025, but the outlook is positive 40.98% per year for the next five years.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
RENAISSANCE TECHNOLOGIES LLC, with 2.3123% or 11.27 million shares worth $13.86 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 10.94 shares worth $38.51 million, making up 2.65% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 6.07 shares worth around $21.38 million, which represents about 1.47% of the total shares outstanding.
